Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Clinical Apheresis|November 18, 2025
Challenges in Trials in Sickle Cell Disease: Thromboprophylaxis in Sickle Cell Disease With Central Venous Catheters (THIS) Pilot StudyJameel Abdulrehman, Stéphanie Forté, George Tomlinson, et al.
Leukemia & Lymphoma|May 16, 2017
Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphomaHaowei Linda Sun, Eshetu G Atenafu, Richard Tsang, et al.
BMJ Open|January 3, 2024
THromboprophylaxis In Sickle Cell Disease with central venous catheters (THIS): an internal pilot randomised controlled trial protocolJameel Abdulrehman, Stephanie Forté, George Tomlinson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 3, 2022
Risk of diabetes in haemophilia patients compared to clinic and non-clinic control cohortsBraj Pandey, Richard F W Barnes, Haowei Linda Sun, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 25, 2022
Diabetes, hepatitis C and human immunodeficiency virus influence hypertension risk differently in cohorts of haemophilia patients, veterans and the general populationRichard F W Barnes, Braj Pandey, Haowei Linda Sun, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 11, 2020
The Clinical Conundrum of Managing Ischemic Stroke in Patients with Immune ThrombocytopeniaAnas Alrohimi, Kaylynn Purdy, Mustafa Alqarni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 30, 2022
Blood pressure in persons with haemophilia with a focus on haemophilia-specific risk factorsAnna Ter-Zakarian, Richard F W Barnes, Rebecca Kruse-Jarres, et al.
Leukemia & Lymphoma|April 18, 2014
Intermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasoneHaowei Linda Sun, Eshetu G Atenafu, Elizabeth Yeboah, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 30, 2017
Patient powered prophylaxis: A 12-month study of individualized prophylaxis in adults with severe haemophilia AHaowei Linda Sun, Kam A McIntosh, Sandra J Squire, et al.
Research and Practice in Thrombosis and Haemostasis|October 20, 2021
The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia BHaowei Linda Sun, Ming Yang, Man-Chiu Poon, et al.
Pageof 4